MEDIPOST's investigational therapy is an umbilical cord blood-derived allogeneic mesenchymal stem cell therapy designed to treat symptomatic cartilage defects in patients with knee osteoarthritis.

Announcing a new publication for Acta Materia Medica journal. Diacerein, an anthraquinone derivative, is emerging as a promising disease-modifying agent in rheumatoid arthritis (RA), because of its ...

Warren Buffett: The career advice 'I told my own kids' from an 1841 Ralph Waldo Emerson essay ...

Arthritis in cats, typically osteoarthritis, is a chronic degenerative joint disease that erodes the smooth cartilage lining the joints, resulting in pain, inflammation and restricted movement—often ...

A cult of clean eating and fitness challenges among the younger generations is putting them at serious risk of developing ...